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Abstract: Being the largest and most visible organ of the body and heavily influenced by 
environmental factors, skin is ideal to study the long-term effects of aging. Throughout our 
lifetime, we accumulate damage generated by UV radiation. UV causes inflammation, 
immune changes, physical changes, impaired wound healing and DNA damage that 
promotes cellular senescence and carcinogenesis. Melanoma is the deadliest form of skin 
cancer and among the malignancies of highest increasing incidence over the last several 
decades. Melanoma incidence is directly related to age, with highest rates in individuals 
over the age of 55 years, making it a clear age-related disease. In this review, we will focus 
on UV-induced carcinogenesis and photo aging along with natural protective mechanisms 
that reduce amount of “realized” solar radiation dose and UV-induced injury. We will 
focus on the theoretical use of forskolin, a plant-derived pharmacologically active compound 
to protect the skin against UV injury and prevent aging symptoms by up-regulating 
melanin production. We will discuss its use as a topically-applied root-derived formulation 
of the Plectranthus barbatus (Coleus forskolii) plant that grows naturally in Asia and that 
has long been used in various Aryuvedic teas and therapeutic preparations.  
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1. Introduction 
Due to its anatomic location at the external boundary of the body, skin is exposed to a variety of 
environmental factors such as UV radiation that derives naturally from the sun. Solar UV exposure is a 
major causative factor for age-related changes such as skin cancer development. UV radiation is 
composed of UVA, UVB and UVC components based on photon wavelength with UVA having the 
longest wavelengths (315–400 nm), UVB being mid-range (290–320 nm) and UVC being the shortest 
wavelengths (100–280 nm). Ambient sunlight is composed primarily of UVA (90%–95%) and  
UVB (5%–10%) energy, with most solar UVC absorbed by the ozone layer (Figure 1).  
Figure 1. UV radiation in ambient sunlight is composed primarily of UVA and UVB 
energy. Most UVC is absorbed by the ozone, therefore although it is highly bioactive, 
terrestrial organisms are not exposed to significant levels of UVC. UVB can cause direct 
damage to DNA and reach the epidermis. UVA can penetrate the dermis and increases 
levels of ROS that indirectly induce DNA mutagenesis. 
 
Naturally occurring UV radiation is the environmental mutagen responsible for the largest percentage 
of environmentally induced skin pathologies, including erythema and inflammation, degenerative 
aging changes, and cancer [1]. Humans are exposed to UV radiation primarily as a consequence of 
unprotected exposure to sunlight [2]. UV radiation has many deleterious effects on cells [3–5]. UV 
radiation produces both direct and indirect DNA damage, and each can result in mutagenesis in skin 
cells. The DNA double helix can absorb energy from shorter-wave UV photons and undergo covalent 
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modification. Neighboring pyrimidines are particularly vulnerable to direct UV damage at the 5–6 double 
bond position. When UV causes this bond to break, abnormal covalent interactions between adjacent 
thymines and/or cytosines can result. There are two main DNA lesions that result from UV-induced 
damage to the 5–6 double bond: (1) cyclobutane dimers formed from two covalent bonds between 
adjacent pyrimidines to form a ring structure; and (2) pyrimidine 6–4 pyrimidone (6,4)- photoproducts 
that form upon reaction of the open 5–6 double bond with the exocyclic moiety of an adjacent  
3' pyrimidine [6]. Both of these lesions distort the double helix and can lead to mutation, and an 
individual skin cell may accumulate up to 100,000 such lesions from one day’s worth of sun  
exposure [7]. UV radiation also damages cellular macromolecules indirectly, through production of 
oxidative free radicals [8]. Several DNA modifications can result from oxidative injury, including  
7,8-dihydro-8-oxoguanine (8-oxoguanine; 8-OH-dG), which promotes mutagenesis (specifically  
GC-TA transversion mutations [9]. Both direct and indirect DNA changes interfere with transcription 
and replication, and render skin cells susceptible to mutagenesis. Much of solar UV energy is absorbed 
by stratospheric ozone, and the gradual depletion of stratospheric ozone over the last several decades 
has resulted in higher levels of solar UV radiation that strikes the surface of the Earth [10]. Increased 
ambient UV radiation from global climate change may be an important factor to explain the burgeoning 
prevalence of melanoma and skin cancer over the last several decades [11–14].  
UVB is a well-characterized mutagen and inducer of skin cancers [15], but recent studies have 
implicated an increasing role of UVA as a carcinogen [16–18] likely through its pro-oxidative effects 
and possibly through other mechanisms such as telomere shortening [19]. In addition, UVA is less able 
to induce melanin production compared to UVB, leaving the skin less able to protect itself against 
further UV insult [15,19–22]. Increasing attention is being paid to the potential impact of UVA 
radiation to the body focusing on differential cellular repair and apoptosis depending on anatomic  
site [23]. The role of UVA in melanoma formation is also suggested by the observation of rising 
melanoma incidence over the last several decades and sunscreen use in the 1980s when only  
UVB-blocking sunscreens were used.  
2. Factors Contributing to UV Exposure 
Geographical variations such as altitude, latitude and urbanization all determine ambient UV 
strength. Because atmospheric particles such as dust or water droplets can scatter, reflect or otherwise 
interfere with UV photons, the more atmosphere sunlight has to traverse, the weaker its energy will be 
at the surface of the Earth. At higher altitudes, with less atmosphere for sunlight to traverse before 
hitting land, there is higher exposure to UV and a higher risk for melanoma. There is a 2% increase in 
risk with every 10 m rise in altitude [24] and in addition those living at altitudes over 1,400 m above 
sea level are at most risk for developing melanoma [25]. In addition to living in high altitudes, 
occupations routinely operating at high altitudes such as airplane pilots and mountain guides have a 
higher incidence of melanoma and precancerous lesions [26,27].  
UV strength is strongest at the equator because sunlight hits the Earth most directly at the equator. 
Toward the poles, sunlight hits the earth obliquely and must pass through more atmosphere. Not 
surprisingly, there is a higher incidence of melanoma in locales closest to the equator, most especially 
among Caucasians [28] who are most UV-sensitive because of lower cutaneous melanin pigments, but 
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also among lower-risk populations of darker skin tone [29]. In a study of the Norwegian Cancer 
Registry, decreased latitude by 10° was associated with a 2–2.5 increased risk of melanoma [30]. 
Another study of 5,700 melanoma cases worldwide found a 1.5-fold increased risk when living at 
latitudes closer than 20° from the equator [31]. Importantly, though latitude risk for melanoma has 
been historically strong, recent studies suggest decreased correlation [32], or even an opposite trend.  
A 2012 study of Northern Europeans, for example, showed an increase in melanoma incidence with 
increase in latitude beyond 50° north of the equator [33], perhaps due to the dramatic rise in artificial 
indoor tanning. 
Urban-versus-rural lifestyle also seems to be important, with as much as a 50% increased melanoma 
risk in urban regions [34]. Urbanization may affect cancer risk by bringing together many independent 
risk factors such as occupational chemical exposure, social pressures regarding skin appearance, easy 
access to indoor tanning, and higher socio-economic levels lending to increased use of indoor tanning 
and holiday travel [35]. The increase in urbanization worldwide and the increase in these activities 
may help explain the rise in melanoma rates for northern Caucasian populations that would otherwise 
not be exposed to natural risk factors such as latitude [24].  
3. Age 
UV exposure may account for up to 80% of visible signs of aging in the skin including dry 
appearance, scalping, wrinkling [15] and impaired pigmentation, and photoaging correlates with 
cancer risk. A 2012 study of Central Europeans, for example, showed those with early signs of 
wrinkling on the neck were over four times more susceptible to melanoma than the general population. 
Freckling on the back also showed over three times the risk [21]. Cutaneous photoaging and melanoma 
risk both correlate with age and UV exposure. The average age of melanoma diagnosis is about 55 and 
incidence varies worldwide from five to over 60 cases per 100,000 people per year [12]. Although 
melanoma is a malignancy mostly diagnosed in the fifth and sixth decade of life, one fifth of cases 
occur in young adults [36,37]. It is important to note, however, that the UV exposure and accumulation 
of DNA damage that underlie melanoma formation begin with sun exposure early in youth, which is 
why sun protection in the pediatric years is so important. There is a significant correlation of melanoma 
risk with excessive sun exposure before adolescence, perhaps contributed to by structural anatomical 
differences between the skin of children and adults making it easier for UV to penetrate [38]. Childhood 
UV exposure also increases the risk of young adult melanoma (melanoma under the age of 30) by over 
three times, showing how exposure can accelerate the process of carcinogenesis [39]. Furthermore, a 
new study published in 2014 of over three million people in Sweden showed that accumulation of UV 
damage begins as early as in the neonate, with melanoma incidence increased in those born in the 
spring and summer versus those born in the fall or winter [40]. Indeed, some estimates indicate that up 
to 80% of lifetime UV exposure occurs before the age of 20 because of the outdoor recreational habits 
of children. 
This risk for melanoma among the middle-aged population has risen in the past few decades. An 
epidemiologic study in Minnesota found an incidence of 60 cases per 100,000 in 2009 compared to 
just eight per 100,000 in 1970; that is a 24-fold increase in risk for this population. Another 
unfortunate finding is the steady increase in occurrence in young adults, particularly for young women 
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in the United States (US). Whereas young American women aged 15–39 had a melanoma incidence 
rate of 6 out of 100,000 cases in 1973, their rate more than doubled to 14 out of 100,000 cases per year 
in 2006 [41]. Because of ongoing recreational UV trends such as increased use of artificial tanning 
sources, melanoma rates are expected to continue to rise [37], making this disease an increasing public 
health threat.  
4. Artificial UV and Tanning Beds 
Indoor tanning use has dramatically risen in the last thirty years and is predicted to continue rising 
largely because of societal and commercial incentives for a tanned appearance viewed by many as 
appealing. In 2013, over 40% of adolescents aged 15 to 18 had tried indoor tanning with about 18% 
using indoor tanning routinely [42]. A recent large-scale systematic review, published in 2014, 
reported that over 50% of college-aged students tried indoor tanning, with over 40% using it in the past 
year. In a 2014 study of college-aged women from 18 to 25 years of age, 25% of current users could be 
classified as tanning-dependent [43]. Similarly, prevalence among American adults may be as high  
as 35% [42,44]. Interestingly, tanning behavior has increasingly been compared to classic “substance 
use” disorders, with some classifying frequent indoor UV patronage as a true addiction [45,46]. 
Tanning-addictive behaviors have been associated especially with young age, other high-risk behaviors 
and psychiatric disorders [45,46]. Indoor tanning involves exposure to high doses of UV with the 
intent to trigger skin pigmentary responses. Tanning beds emit varying blends of UVA and UVB 
energy, and their use is clearly linked with photoaging, keratinocyte malignancies and melanoma. 
Generally, most basic tanning beds emit a blend of UVB and UVA radiation with more advanced beds 
emitting mostly UVA radiation to emulate natural UV radiation. However, with UVA now firmly 
implicated in melanoma carcinogenesis, such beds may be no safer than those with higher UVB 
output. Alarmingly, despite strong epidemiologic data correlating younger age of tanning bed use with 
skin cancers, tanning bed use among minors is poorly regulated and its use increasing. In 2013, the 
National Conference of State Legislatures of USA approved new laws limiting or banning the use of 
tanning beds by adolescents, however actual laws that govern indoor tanning among minors vary by 
state with most states not prohibiting use among minors. Use of tanning salons before the age  
of 35 years is associated with a 75% increased lifetime melanoma risk [47], therefore the increasing 
use of tanning beds may be an important factor to explain the increasing incidence of melanoma in 
recent decades.  
5. Sunburns and Melanoma 
Overexposure to UV is a key factor in development of skin cancers, and melanoma incidence 
correlates particularly with intermittent intense UV exposures that cause sunburn. More than five 
sunburns in a lifetime doubles risk for melanoma and there is increased risk for melanoma as a young 
adult if there are increased sunburns in childhood [31,39,48]. The melanoma-sunburn link may reflect 
the contribution of inflammatory mediators to carcinogenesis or perhaps a particular threshold above 
which the dose of UV must exceed in order to transform melanocytes. Nonetheless, intense blistering 
sunburns seem to play a role in many cases of melanoma. Unfortunately, over half of all adults in the 
US suffered from sunburn in 2013 and prevalence of sunburn in the US population today is over 50% 
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in all adults and over 65% in fair-skinned young adults under the age of 30. Furthermore, prevalence 
of sunburn has not declined despite the variety of lotions, sprays and clothing advertised and available 
for sun protection [49]. Risk of sunburn is complex and influenced by a variety of factors ranging from 
geography, cloud cover, climate, societal norms relating to amount of clothing worn, etc. Not surprisingly, 
incidence of sunburns in children (and indoor tanning use among adolescents) correlates with parental 
attitudes regarding sun protection. For this reason, educational campaigns targeted at parents’ ideas 
about UV safety might be particularly useful for prevention and protection against UV-induced skin 
pathologies [50].  
6. The Melanocortin 1 Receptor (MC1R) and the Tanning Response  
One important aspect of the solar radiation in human’s skin is the adaptive tanning response. After 
UV exposure, cellular damage response activation induces melanin production by melanocytes and 
proliferation and melanin deposition in keratinocytes, all of which result in enhanced pigmentation of 
the skin. This important physiologic pathway is a natural UV-protective response to protect the skin 
against further UV insult after an initial UV exposure. The ability of the skin to tan depends on the 
function and activity of the cutaneous melanocortin 1 receptor (MC1R) signaling pathway [51–55] 
(Figure 2).  
Figure 2. MC1R signaling cascade in melanocytes. Activated by its agonist alpha-MSH, 
MC1R promotes cAMP second messenger generation which induces melanocyte 
differentiation and survival pathways involving PKA, CREB and Mitf. In this way, cAMP 
induces both melanin production and antioxidants that reduce cellular ROS. cAMP, cyclic 
adenosine monophosphate. PKA, protein kinase A. pCREB, phosphorylated cAMP 
response binding element. ROS, reactive oxygen species. MITF, microphthalmia (Mitf) 
transcription factor. 
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The MC1R is a Gs-couple protein located in the extracellular membranes of epidermal melanocytes. 
When bound by agonistic ligands, most notably α-melanocyte stimulating hormone (α-MSH) [51], the 
MC1R initiates a cascade of UV-protective events mediated by activation of adenylyl cyclase and 
generation of the second messenger cAMP. MC1R activates adenylate cyclase that converts ATP to 
cAMP which activates protein kinase A (PKA). PKA phosphorylates the cAMP-responsive binding 
element (CREB) and induces activation of the microphthalmia (MITF) transcription factor. MITF is a 
myc-like master transcription factor that, in melanocytes, drives expression of tyrosinase and other 
pigment biosynthetic enzymes. In this way, epidermal melanocytes produce melanin pigment that gets 
deposited in the epidermis to physically interfere with penetration of UV photons, thereby protecting 
skin cells from the damaging effects of sunlight [56]. Importantly, MC1R signaling also influences the 
ability of melanocytes to recover from UV-induced DNA damage [57–61]. Overall, there is much 
evidence placing MC1R as a “master regulator” of melanocyte UV physiologic responses.  
7. Pigmentation Phenotype Depends on MC1R Signaling 
Loss-of-function polymorphisms of MC1R lead to a fair-skinned, sun-sensitive, and cancer-prone 
phenotype [62–64]. The major MC1R polymorphisms among human populations are the so-called “red 
hair colored” (RHC) genotypes that yield a characteristic UV-sensitive and melanoma-prone phenotype, 
namely propensity for sun burning rather than tanning, fair skin complexion, freckling and red/blonde 
hair. The RHC phenotype include R151C, R160W and D294H MC1R genotypes [65–67]. In these 
cases, there is blunted cAMP production in melanocytes, and the skin produces less of the highly  
UV-protective dark brown/black pigment species known as eumelanin. Instead, there is production of 
a red/blonde pigment known as pheomelanin that is much less effective at blocking incoming UV 
energy and may even potentiate UV-induced oxidative injury. Without effective cAMP induction in 
melanocytes, as is the case in MC1R-defective individuals, the skin cannot accumulate significant 
amounts of eumelanin and therefore will be prone to UV damage and carcinogenesis.  
8. Forskolin Rescues cAMP Deficient Signaling 
Forskolin is a naturally derived diterpenoid extracted from the roots of the Plectranthus barbatus 
(Coleus forskolii) plant that grows naturally in Asia and that has long been used in various Aryuvedic 
teas and therapeutic preparations. Forskolin, which is a skin-permeable compound, directly activates 
adenylate cyclase to induce production of cAMP. Our laboratory was among the first to show that 
topical application of forskolin promoted UV-independent production of eumelanin in an MC1R-defective 
fair-skinned animal model [53], resulting in robust UV protection by interfering with epidermal 
penetration of UV photons [68]. Pharmacologic stimulation of cAMP using forskolin may protect the 
skin in ways other than through melanin induction. For example, cAMP provided enhancement of 
keratinocyte migration to promote wound healing [69] and it also decreased blister formation [70].  
De Vries and co-workers proposed using a topical cAMP approach to regulate beta-adrenergic 
response in psoriasis patients [71]. Interestingly, cAMP stimulation has also been studied as an 
activator of hair follicle activity and has been considered as a therapy for age-related hair loss [72,73]. 
We and others have been interested in the UV-protective consequences of topical cAMP induction to 
promote melanin protection from UV-mediated DNA damage [68] and to enhance levels and/or 
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activity of key DNA repair and antioxidant enzymes [74]. Forskolin and other cAMP-promoting 
agents may also protect the skin against UVB-induced apoptosis [75] and by promoting epidermal 
thickening which also aids in resisting UV damage [76]. In particular, Scott et al. reported that  
cAMP-mediated accumulation of basal and epidermal keratinocytes resulted in a melanin-independent 
mechanism of blocking UVA and UVB penetration into the skin [76]. Others reported that forskolin 
protected against generation of oxidative stress by decreasing levels of nitric oxide [77] and enhancing 
stimulation of the cytoplasmic antioxidant enzyme copper/zinc superoxide dismutase (Cu/ZnSOD) [78]. 
Taken together, studies suggest that pharmacologic induction of cAMP in the skin may represent a 
potential UV-protective strategy for MC1R-defective individuals who are fair-skinned, sun-sensitive 
and melanoma prone.  
9. Oxidative Stress and Aging 
Reactive oxidative species (ROS) are produced by cells during normal metabolic activities such as 
mitochondrial oxidative phosphorylation, however levels of ROS vary with UV exposure and levels of 
antioxidant enzymes. Figure 3 shows a simplified scheme of the location of protective antioxidant 
enzymes in the cell (Figure 3).  
Figure 3. Cellular antioxidant defenses. UV induces a variety of free radical and oxidative 
molecules, which because of their chemical reactivity alter the molecular structure and 
damage lipids, proteins and nucleic acids [79]. Antioxidant enzymes mediate the removal 
of ROS, with different enzymes functioning in specific compartments (e.g., MnSOD 
localized to mitochondria). If not removed, ROS may react with DNA and other cell signal 
proteins, impairing their function. ECSOD, Extracellular Superoxide dismutase. Cu/Zn 
SOD, copper/zinc superoxide dismutase. MnSOD, Manganese Superoxide dismutase. 
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Without inactivation, ROS damage macromolecules including lipid, proteins and DNA. UV, 
particularly longer-wavelength UVA, is a well-known inducer of ROS, and UV-induced oxidative 
stress may be an important contributive factor for melanoma [80–82]. ROS can inappropriately 
activate signaling pathways, interfere with genome maintenance and affect apoptosis. Numerous 
studies have tested the effects of solar radiation and oxidative stress on the skin [29,83–85], and 
oxidative stress has been linked to age-related loss of skin elasticity [86–88], defective cellular 
signaling [68] and photoaging [89,90]. Because it triggers cellular damage pathways, oxidative stress 
activates cellular senescence which is thought to directly lead to photoaging [91–94]. Cellular 
senescence is associated with a reduced capacity to divide and proliferate, sometimes in conjunction 
with shortening of telomeres [95–98]. Yokoo et al. found that exposing cells to a pro-oxidant agent 
(H2O2) impaired telomerase function which eventually resulted in telomere shortening, decreased 
proliferation and cellular enlargement [97]. Wrinkling of the skin is one of the most overt signs of 
photoaging, and UV exposure can induce wrinkling over time [99–102]. Though the molecular 
mechanism(s) of wrinkling are likely to be complex, UV exposure may reduce elastic properties of the 
skin to alter the three-dimensional structure of elastic fibers [103]. Using an animal model, Shin et al. 
noted an inverse correlation between wrinkling and important antioxidant enzymes that reduce cellular 
levels of ROS [104]. Thus UV-induced oxidative cutaneous damage may play a major role in photoaging.  
Cells have a network of antioxidants and antioxidant enzymes that function to inactivate ROS and 
limit free radical injury. Because they house the enzymes that mediate the electron transport chain, 
mitochondria are the main intracellular source of endogenous levels of ROS. Manganese superoxide 
dismutase (MnSOD), a mitochondrial protein, is a major regulator of ROS in the mitochondria. 
Glutathione is the most widely expressed antioxidant in the cell, and its levels and oxidation state are 
regulated by feedback signaling dependent on total ROS level. Increases in ROS lead to use and 
depletion of glutathione and trigger recruitment of antioxidant enzymes such as catalase and superoxide 
dismutases (SODs).  
Many synthetic and natural products have been reported to enhance levels of antioxidant enzymes, 
which make them therapeutic candidates to mitigate UV-mediated damage and to prevent the health 
consequences of UV exposure. Some products include alpha-tocopherol, selenium, phloretin, ferulic 
acid, flavangenol, lipoic acid, and uric acid [57,105–111] as well as a variety of flavonoids derived 
from plants including pomegranate and strawberry [112,113]. Lipid-soluble carotinoids such as 
lycopene and beta-carotene have been reported to scavenge superoxide radicals [114] and to promote 
vitamin A activity [115]. However, large doses of UV may inactivate carotenoids in the skin and 
promote degradation of dermal collagen and elastin [114,116]. Vitamin C is another anti-oxidant 
compound that has been studied as a UV photoprotective agent [108], particularly in combination with 
other compounds such as ferulic acid and phloretin [108].  
There is emerging evidence implicating MC1R and cAMP signaling in regulating antioxidant 
proteins. Using keratinocytes transfected with MC1R, Henri et al. reported lower cellular levels of 
ROS after pharmacologic activation MC1R/cAMP pathway and higher levels of ROS when PKA was 
pharmacologically inhibited [117]. In other work using human melanocytes, Song and colleagues 
found that αMSH-induced MC1R signaling increased levels of catalase after UV exposure. Catalase is 
an antioxidant enzyme that converts excess of hydrogen peroxide molecules to water and molecular 
oxygen [118]. Finally, Kaderaro and coworkers reported that cAMP stimulation reduced levels of 
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hydrogen peroxide, an important ROS, in human melanocytes after UV exposure [74]. Therefore, there 
is great interest in exploiting the MC1R UV-protective signaling pathway as a protective mechanism 
against UV-mediated oxidative injury.  
10. Conclusions 
UV exposure is one of the most important environmental health hazards, clearly causative for  
age-related skin changes such as wrinkling, pigmentary changes, thinning and carcinogenesis.  
Because of complex societal factors, UV exposure may actually be increasing through increased 
occupational and recreational activities including indoor tanning. As we learn more about innate 
signaling mechanisms that regulate natural antioxidant defense pathways in the skin such as the MC1R 
hormonal axis, new approaches are being designed to exploit these signaling pathways to delay or even 
prevent free-radical induced symptoms of aging. Use of natural extracts such as forskolin derived from 
the roots of the Plectranthus barbatus (Coleus forskolii) plant may enhance protection against  
UV-induce molecular damage to the skin. cAMP-induced melanin deposition and antioxidant 
induction may prove to be an important therapeutic opportunity to reduce UV-mediated pathologies.  
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